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5-HYDROXYTRYPTAMINE (enteramine, serotonin; henceforth abbreviated as
5-HT) is generally agreed to be a substance ofconsiderable, though still somewhat
undefined, physiological importance. Its formation and degradation are known
to follow the pathway shown in Fig. 1 (Udenfriend, Clark and Titus, 1953b;
review, Dalgliesh, 1955). In cases of metastasizing tumours of the argentaffin
cells (carcinoids, argentaffinomas) abnormally large amounts of 5-HT are formed,
producing a syndrome first clearly recognized by Waldenstrom and his colleagues
(Thorson, Bi6rck, Bjorkman and Waldenstrom, 1954).
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F.TG. .-The pathway for formation and degradation of 5-HT.
The reaction bywhich 5-HT is formed from its immediateprecursor, 5-hydroxy-
tryptophan, has been extensively studied, notably by Gaddum and Giarman
(1956), and the appropriate enzyme, 5-hydroxytryptophan decarboxylase, is
known to be of widespread occurrence, the relative amounts in different tissues
being to some extent parallel to the relative tissue contents of 5-HT. On the other
hand very little information is available on the reaction by which tryptophan
is converted to 5-hydroxytryptophan, and only circumstantial evidence appears
to be available to show that the reaction occurs in mammalian tissues.
5-HT appears likely to prove to be ofconsiderable importance in brain function.
It is unlikely that brain 5-HT is derived from circulating blood 5-HT, as 5-HT
will not penetrate the blood-brain barrier (a fact confirmed by the absence of
mental symptoms in patients with argentaffinoma). On the other hand 5-hydroxy-
tryptophan penetrates the blood-brain barrier readily (Udenfriend, Bogdanski
and Weissbach, 1956) and injection of 5-hydroxytryptophan, unlike 5-HT,BIOGENESIS OF 5-HYDROXYTRYPTOPHAN
will cause a rise in brain 5-HT levels, as is to be expected from the presence of
5-hydroxytryptophan decarboxylase in the brain.
Although the 5-HT circulating in the blood is, under normal circumstances,
contained entirely in the platelets, the platelets are known not to be the site of
synthesis. However platelets take up 5-HT from solution (Humphrey and Toh,
1954) and there are many sites (e.g., the intestinal tract; Toh, 1954) where the
presence of large amounts of 5-hydroxytryptophan decarboxylase suggests that
the circulating platelets may acquire their 5-HT. There is, however, no evidence
that the 5-hydroxytryptophan is formed at the same sites at which it is decarboxy-
lated.
The present paper describes an investigation of the problem of 5-hydroxy-
tryptophan formation. The above lines of reasoning suggested that 5-hydroxy-
tryptophan might be formed at some central site, and distributed by the blood to
the organs for local formation of 5-HT by decarboxylation. As the liver is the
site ofother hydroxylation reactions ofaromatic amino acids, e.g., ofphenylalanine
to tyrosine (Udenfriend and Cooper, 1952) and ofkynurenine tohydroxykynurenine
(de Castro, Price and Brown, 1956) we paid particular attention to liver prepara-
tions. This work has been the subject of a preliminary communication (Dalgliesh
and Dutton, 1957).
MATERIALS AND METHODS
['4C]Tryptophan was prepared biosynthetically. (Dalgliesh and Dutton, 1956).
5-Hydroxyindoles. 5-Hydroxytryptamine creatinine sulphate was given by,
or purchased from, Roche Products Ltd., Welwyn Garden City, and Sandoz
Products Ltd., London, W.1. 5-Hydroxyindoleacetic acid was given by Roche
Products Ltd., Welwyn Garden City, and the Upjohn Company, Kalamazoo,
Michigan, U.S.A. 5-Hydroxytryptophan was given by Dr. G. L. Martin and the
National Drug Company, Philadelphia, U.S.A.
Amine oxidase inhibitor.-Choline p-tolyl ether.was given by Professor W. A.
Bain (cf. Brown and Hey, 1956).
Animals.-Rats were "hooded " females weighing 200-250 g. White mice
were of the National Institute for Medical Research strain.
Other materials.-" Dextraven " dextran (Benger Laboratories Ltd., Holmes
Chapel, Cheshire), "Liquemin" heparin (Roche Products Ltd.) and triphospho-
pyridine nucleotide (sodium salt; Sigma Chemical Co., St. Louis, Missouri)
were purchased.
Paper chromatography was carried out by the two-dimensional procedure of
Dalgliesh (1956) on urine extracts prepared by the methods of Asatoor and
Dalgliesh (1956). In chromatograms for autoradiography the solvent for the
second dimension was isopropanol-0.880 ammonia-water (200: 5: 20 by volume)
instead of aqueous KC1 (to eliminate absorption of radiation by KC1 left in
the paper after drying). This alkaline solvent causes slight decomposition of
5-hydroxyindoles.
Autoradiography of paper chromatograms was carried out on Ilford X-ray
film.
Determination of 5-hydroxytryptophan decarboxylase activity.-Approximately
250 mg. oftissue slice were incubated at 38° inKrebs-Ringer bicarbonate (Umbreit,
Burris and Stauffer, 1949) containing 88/tg./ml. 5-hydroxytryptophan and 1 mg./ ml. choline p-tolyl ether, in a total volume of 5 mnl. In the expriments in whichC. E. DALGLIESH AND R. W. DUTTON
direct comparison was made with Gaddum and Giarman's (1956) results, tissue
homogenate was used instead of slices, and the amount of amine oxidase inhibitor
used was as in Gaddum and Giarman's work. Tissue slices were prepared either
by hand using a razor, or with a mechanical chopper (Mcllwain and Buddle,
1953) similar results being obtained with tissues prepared by the two methods.
The 5-hydroxytryptamine was determined as described below.
Determination of 5-HT.-The method was based on that of Udenfriend,
Weissbach and Clark (1955) which involves extraction into butanol from an
alkaline salt-saturated solution, followed by two washings with borate buffer,
pH 10, and then addition of heptane and re-extraction into dilute hydrochloric
acid. The following modifications were made: (a) to obtain good recoveries of
5-HT it was found essential to have the pH of the borate buffer between 9-5 and
9*8; and (b) the 5-HT was finally extracted into 3N-HC1 instead of dilute HC1,
and the 5-HT determined fluorimetrically (cf. Udenfriend, Bogdanski and Weiss-
bach, 1955) using the fluorimeter of Laurence (1957), instead of colorimetrically.
The filter for the exciting light was a 3 cm. quartz cell containing a mixture of 2
parts of a saturated solution of cobalt sulphate and 1 part of a saturated solution
ofnickel sulphate. The filter for the emitted light was a Chance OY 18. Calibration
curves were made for each set of determinations. The method was satisfactory
down to 0 02 ,tg. 5-HT/ml.
A further modification of Udenfried, Weissbach and Clark's (1955) procedure
was made if the extract was to be used for chromatography The final washing
of the butanol extract was made with distilled water adjusted to pH 10. This
removed most ofthe salt from the butanol and resulted in only small loss of 5-HT.
Determination of 5-HIAA was by our modification (Macfarlane, Dalgliesh,
Dutton, Lennox, Nyhus and Smith, 1956) of the method of Udenfriend, Titus
and Weissbach (1955).
Separation of mouse intestinal mucosal preparation. The entire small intestine
(from stomach to caecum, exclusive) was removed, placed on a glass plate at 00,
and cut into short lengths. The gut contents were then squeezed out by light
pressure, and washed away. The inner coat of the mucosa could then be squeezed
out by firmer pressure to give a " mucosal preparation". The 5-HT content of
the mucosal preparation so obtained agreed closely with the 5-HT content of
whole gut, showing that recovery of mucosa was essentially quantitative.
Preparation of rat intestinal mucosa.-In this case the small intestine was cut
open, washed, and the mucosa scraped off.
Incubation experiments u'ith tissue preparations
The following is a typical procedure, in an experiment with unlabelled trypto-
phan: approxinately 250 mg. mouse intestinal mucosal preparation was incu-
bated with L-tryptophan (final concentration 250 ,ug./ml.) and choline p-tolyl
ether (final concentration 1 mg./ml.) made up to a total of 5 ml. in M/15 phosphate
buffer, pH 8. Two controls were run simultaneously, one with tryptophan
omitted, and the other with tryptophan replaced by 5-hydroxy-DL-tryptophan.
At suitable times the mixtures were extracted for 5-HT determination as described
above.
The following is a typical experiment with labelled tryptophan: 250 mg.
mouse liver slices were incubated in buffer as above with a total of 440 ,tg.
5-hydroxy-DL-tryptophan, 300 ,ug. 5-HT and 84 ,ug. (containing 1X4 ItC) of
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L-['4C]trvptophan (the 5-hydroxytryptophan and 5-HT were to " trap " any
labelled metabolites that might be formed; in other experiments the 5-hydroxy-
trylptophan was omitted). After incubation for a suitable period (e.g., 1 hour) the
mixture was extracted and the concentrated extract submitted to one- or two-
dimensional paper chromatography, followed by autoradiography and/or scanning
of the resultant chromatogram. The position of the 5-hydroxyindoles on the
chromatogram was then determined using Ehrlich's reagent (p-dimethylamino-
benzaldehyde in HRC).
Incubation experiments with liver mitochondria
Rat liver mitochondria were prepared by the method of Hogeboom (1955).
Ox liver mitochondria were given by Drs. G. Popjak and P. Hele. The mito-
chondria preparations were tested by comparing respiration rates on incubation
with oc-oxoglutarate in the presence and in the absence of malonate as an inhibitor
(Copenhaver and Lardy, 1952). They were further tested by examining their
ability to carry out the conversion of kynurenine to hydroxykynurenine under
the conditions described by de Castro, Price and Brown (1956).
A typical experiment with unlabelled tryptophan was as follows: A mixture
of a rat liver mitochondrial suspension (0.3 ml., equivalent to 500 mg. liver),
50 (t),mole citrate (in 0.1 ml.), 0-67/amole TPN (in 0 1 ml.), 2-5 ,umole L-tryptophan
(in 0.1 ml.), 33 ,tmole nicotinamide (in 0-2 ml.) and 005 M phosphate buffer,
pH 7*4 (0.9 ml.) was incubated for 2 hours at 37°. The incubate (20 pl. portions)
was then spotted on the origin of chromatograms. The remaining incubate was
then treated with deactivated charcoal (Asatoor and Dagliesh, 1956) and the
adsorbed aromatic substances eluted with aqueous phenol, concentrated and run
on paper chromatograms, with spots of known 5-hydroxyindoles for reference.
As a control a similar incubation was carried out with kynurenine instead of
tryptophan, and the final chromatograms were examined for the presence of
hydroxykynurenine.
A typical experiment with 14C-labelled tryptophan was as follows: The mixture
was made up as above with in addition, 15 ,ug. L-[U-14C] tryptophan (containing
0-23 I1C.), and 44 /tg. unlabelled 5-hydroxy-DL-tryptophan to act as trapping
agent. Chromatography, autoradiography and scanning for radioactivity were
carried out by the usual procedures.
Perfusion apparatus
This is illustrated diagrammaticallv in Fig. 2. The circulating fluid consisted
of 75-150 ml. oxygenated Locke's solution. From the lower reservoir, A, consisting
of a wide open-mouthed funnel with sintered glass disc (7 cm. diam., porosity 1)
and tap, the fluid descended to a small chamber, B, into which oxygen was con-
tinuously admitted at a pressure of about 2 lb./sq. in. The fluid then rose to a
water jacketed spiral, c, from the top ofwhich the oxygenated fluid passed through
a splash-head, D, into an upper reservoir, E. An overflow pipe drained the fluid
in excess ofperfusion requirements back into the lower reservoir, A. Theperfusing
fluid was then led through another jacketed spiral, F, having an exposed loop
of rubber tubing, G, to allow substances to be injected into the perfusion stream
(e.g., methylene blue at the end of a perfusion). The lower end of the spiral,
F, was connected to a long length of rubber tubing (80 cm. long, and 1.5 mm.
bore) connected to the cannula, This allowed dissection to be carried out on a
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nearby table and the cannula inserted whilst attached to the perfusion apparatus.
The liver or gut was not removed from the animals; instead the dissecting board,
H, carrying the animal was placed in a chamber (formed from a 2 1. beaker)
containing a 25 w. electric light bulb which was found suitable to maintain the
> LO 02
FIG. 2.-Diagram of perfusion apparatus used. For explanation, see text.
internal temperature (thermometer, Th) ofthe chamber at 37°. After perfusion the
fluid passed into the lower reservoir, A, for further circulation.
Substrateadditionsweremadefrom a syringe, carriedona board, I. Theplunger
of the syringe was depressed by an arm moving along gearing attached to the
spindle of an electric clock motor, J. K is a micro-switch stopping the motor after
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complete delivery. In all perfusions the perfusing fluid contained 1 ml. (1000 i.u.)
heparin.
Circulation of the perfusion fluid was due to a lift pump action, the weight of
the unbroken column of fluid between A and B exceeding the weight of fluid in
the ascending column in which the fluid was broken up by bubbles ofoxygen.
Through the jackets of the spirals c and F there was continuously circulated
water at 38°. This was derived from a reservoir, R (the bath of a Warburg
apparatus) and was conveniently circulated by an Archimedean screw, consisting
of a laboratory stirrer (driven by the motor, M) closely fitting inside a piece of
wide polythene tubing, P, arranged inside a 2 1. measuring cylinder, s, as shown.
Heating water circulated through the upper spiral, c, by siphoning, whicM could
be initiated bymeans ofthe uppertap shown. TT represents laboratory scaffolding.
Liver perfusion
The glass inlet cannula was placed in the hepatic portal vein and the outlet
cannula in the inferior vena cava.
Gut perfusion (Fig. 3)
The gut was not removed from the animal. The inlet cannula, H, (a stainless
steel a in. hypodermic needle, size 21 g.) was placed in a cut, I, in the aorta. The
outlet cannula (glass) was inserted in the hepatic portal vein just below the liver.
FIG. 3.-Diagrammnatic representation of technique used in gut perfusion. For explanation, see text.
L1 is a ligature tied over the inlet cannula, L2 isolates the arterial and venous supply
to the right kidney (R.K.), L3 and L4 isolate the left kidney (L.K.) and a cut between
L3 and L4 gives access to the aorta, which is ligatured at L5 and L6. v represents
the inferior vena cava, C.A. the coeliac axis, and s.M. and I.M. the superior and
inferior mesenteric arteries.
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RESULTS
5-Hydroxytryptophan Decarboxylase
5-Hydroxytryptophan, being an amino acid, cannot be conveniently extracted
from aqueous solution by an organic solvent, and such an extraction is desirable
to allow separation from precursor tryptophan of 5-hydroxyindole derivatives.
Any 5-hydroxytryptophan formed was therefore either allowed to undergo de-
carboxylation byendogenous 5-hydroxytryptophan decarboxylase in thepresence
of an amine oxidase inhibitor, so that the 5-hydroxyindole isolated was 5-HT,
or the amine oxidase inhibitor was omitted, in which case the 5-hydroxyindole
is to be expected mainly in the form of 5-hydroxyindoleacetic acid (5-HIAA).
The 5-hydroxytryptophan decarboxylase activity of the tissues under investiga-
tion was therefore examined to determine the degree of conversion of 5-hydroxy-
tryptophan to 5-HT that might be expected.
Preliminary experiments showed that choline p-tolyl ether caused sonme
depression of 5-HT fluorescence, e.g., the fluorescence of a solution of 2.5 /tg.
5-HT/ml. in the presence of inhibitor at 500 ,ug./ml. was depressed to 79 per cent
of the control value. Corrections were therefore made where necessary, by
including appropriate controls.
Amine oxidase inhibitor was incorporated in incubation mixtures at concentra-
tions up to 1 mg./ml. Concentrations much lower than this were adequate to
inhibit breakdown of 5-HT in liver preparations, but even higher concentrations
did not completely inhibit breakdown in intestinal mucosal preparations. e.g.,
5-HT at a concentration of 5 ,ug./ml. showed 30 per cent disappearance after 60
minutes in presence of 1 mg./ml. choline p-tolyl ether and a homogenate of mouse
mucosal preparation (and 80 per cent breakdown in absence ofinhibitor). Curves
for time plotted against 5-HT formation from 5-hydroxytryptophan in presence
of tissue homogenates showed an approximately linear increase for 30 minutes.
When the initial rate was plotted gainst substrate concentration (Fig. 4) the
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FIG. 4.--Dependence of initial rate on substrate concentration for 5-hydroxytryptophan
decarboxylase in mouse intestinal mucosal preparations. The arbitrary units for the initial
rate correspond to fluorimeter readings obtained on determining 5-HT formed after 30
minutes.
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optimal substrate concentration was found to be about 200 ,ug./ml. and the
substrate concentration for halfmaximal rate (i.e., Kin) 35,tg./ml. or 1.6 X 10-4 M,
or half this value ifit is assumed that only the L-isomer is decarboxylated.
For determination ofdecarboxylase activity we used a substrate concentration
of 88 ,ag./ml. (4 x 10-4 M) to facilitate comparison of our results with those of
Gaddum and Giarman (1956). Results obtained with various tissues of the mouse
are given in Table I, and some of our results are compared with analogous results
of Gaddum and Giarman in Table II. The enzyme activities as indicated by
TABLE I.-Formation of 5-HT from 5-Hydroxy-DL-tryptophan in Various
Tissues of the Mouse
Results are expressed as ag. 5-HT formed/g. wet weight tissue/hour,
using a substrate concentration of88jg./ml. (4 X 10-4M) andamineoxidase
inhibitor concentration of 1 mg./ml. Reproducibility is indicated by results
obtained with preparations made on different occasions.
5-HT present
Tissue After 20 After 40 After 60 Initial
minutes minutes minutes rate (mean)
Liver . . . 187 422 344 . 570
191 390 329
206 322 284
Intestinal miucosa ]135 125 145 . 600
106 108 87
Kidney . 100 260 369 . 450
148 365 430
Brain (whole) . . 17 25 92 . 80
19 46 67
13lood . . . 0 0 0 . 0
0 0 0
TABLE II.-Comparison of Values Obtainedfor 5-Hydroxytryptophan Decarboxylase
Activity of the Gut Using the Conditions of Gaddum and Giarnman (1956)
Results expressed as /ag. 5-HT formed/g. wet weight tissue/hour from
4 X 10-4 M 5-hydroxy-DL-tryptophan.
Gaddum and Giarman (1956) Present work
--- ~
· i--./
Tissue GCuinea-pig Rat Rat Mouse
Kidney . . 200 120 . - 400
Liver . . 25 20 420 337
Duodenum .1275 - 40 (400*) .116 (460*)
Ileum 88.4 - f
*Values calculated from initial rates.
initial rate determinations in our experiments are in many cases appreciably
higher than previously found, and indicate the high tissue activity ofthis enzyme.
Any hydroxytryptophan formed in our experiments would, in the absence of
added hydroxytryptophan, thus be expected to be transformed to hydroxytrypt-
amine as fast as it was formed. But in addition, especially in the case of intestinal
mucosal preparation, if only a small amount of 5-HT were formed it might be
degraded as fast as formed. It was not determined whether or not the disap-
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pearance of 5-HT in intestinal mucosal preparations even in the presence of large
amountsofanamine oxidase inhibitorwasdueto analternativemetabolicpathway.
Marsalid (iproniazid; 1-isopropyl-2-isonicotinylhydrazine) was used as an
amine oxidase inhibitor in a few experiments. It had no advantages over choline
p-tolyl ether.
As the rates ofdecarboxylation foundin ourexperiments werehigherthanthose
found by Gaddum and Giarman (1956) several experiments were carried out to
determine whether the product formed under our conditions was in fact 5-HT.
That this was the case was indicated by the following results:
(a) The substance estimated fluorimetrically as 5-HT was found on paper
chromatograms to give a spot of the same RFas authentic 5-HT.
(b) Semni-quantitative estimation of the substance on paper chromatograms,
using the colour reaction with Ehrlich's reagent (p-dimethylamlinobenzaldehyde
in HC1) gave values agreeing with the fluorimetric estimation.
(c) The ultraviolet absorption spectrum of the substance extracted fromn
chromatograms agreed with that of authentic 5-HT, and optical density deter-
minations gave values within 3 per cent of those determined fluorimetrically.
(d) Determinations of the 5-hydroxytryptophan remaining (using the nitro-
sonaphthol reagent as for the other 5-hydroxyindoles; only an approximate
determination is possible as the 5-hydroxytryptophan cannot conveniently be
extracted for purification) agreed with values to be expected from the 5-HT
formed.
(e) The 5-HT in two experiments was kindly estimated pharmacologically,
using the oestrous rat uterus, by Dr. R. S. Stacey, to whom we are most grateful,
and the results corresponded with those determined fluorimetrically.
The reason for the differences between our results and those of Gaddum and
Giarman (1956) is not clear. Possible reasons are that the amine oxidase inhibitor
was acting more efficiently in our experiments or that our procedure for isolating
5-HT after incubation was more efficient, or led to less non-enzymic oxidative
breakdown of 5-HT.
The Tryptopharn Hydroxylation Reaction
Experiments with tissue preparations
In experiments with unlabelled tryptophan the incubation mixtures were
extracted at a suitable pH and examined for 5-HT (if amine oxidase inhibitor
had been present in the incubation) or 5-HIAA. Using rat or mouse liver or
intestinal mucosal preparations no formation of 5-HT or 5-HIAA was detectable,
whereas 5-hydroxytryptophan added to controls showed a normal conversion.
Inexperimentswith[14C]tryptophan unlabelled 5-HT (ifamine oxidase inhibitor
was present), or unlabelled 5-HIAA, or both, was added to trap any labelled
metabolites formed. Again no formation of 5-hydroxyindoles was demonstrable.
It is conceivable that the choline p-tolyl ether inhibited the hydroxylation
reaction, but this could not have occurred in those experiments in which the amine
oxidase inhibitor was omitted and the incubation mixture was examined for
5-HIAA. It is also possible that 5-HT or 5-HIAA added as carrier in the metabolic
experiments did not mix with endogenously formed 5HT or 5-HIAA. It is more
likely however that the negative results were due to absence of, or inactivation of,
the enzyme system.
304BIOGENESIS OF 5-HYDROXYTRYPTOPHAN
Experiments with liver mitochondria
The conditions in these experiments were based on those used by de Castro,
Price and Brown (1956) for conversion of kynurenine to 3-hydroxykynurenine.
The latter reaction proceeded readily with our preparations, but, using either
unlabelled or 14C-labelled tryptophan, no formation of 5-hydroxytryptophan
or derived 5-hydroxyindoles could be detected. Recovery experiments on the
isolationprocedure were carried out, andit was calculated that intheseexperiments
a 2 per cent conversion of tryptophan to 5-hydroxytryptophan would have been
detectable.
Perfusion experiments with liver
A simple and efficient perfusion apparatus was devised (see experimental
section) which can be made from easily available laboratory apparatus. This
apparatus was based on, but differed appreciably from, those of Miller, Bly,
Watson and Bale (1951), Brauer, Leong, McElroy andHolloway (1956), andGordon
(1956). After perfusion for 1 hour or 2 hours typical rat livers were examined
histologically by Dr. A. G. E. Pearse and were found to be in good condition.
At the end of all perfusion experiments methylene blue was injected into the per-
fusion fluid. Rapidreduction occurred. Afterremovalfromthe apparatusthe liver
was sectioned, and the complete circulation of the perfusing fluid confirmed by
reappearance of the colour of the methylene blue in all vessels. The flow rate was
about 20 ml./min. and the oxygen supply was calculated to be adequate to keep
the liver fully oxygenated. [14C]Tryptophan was incorporated into liver protein to
the extent of 8 per cent after 1 hour, comparable with the incorporation after a
corresponding period in vivo (Dalgliesh and Tabechian, 1956). We considered
that these results indicated that the livers were functioning normally during the
perfusion period, and that if the hydroxylation of the 5-position of tryptophan
occurred in the liver it should therefore be detectable.
Liverwasperfused,ingeneralfor 1hour,withfrom 1 to 5 ac.L-[U-14C]tryptophan,
in some cases with unlabelled carriertryptophan added, in'others without. Control
experiments showed that unlabelled 5-HT, 5-HIAA or 5-hydroxytryptophan in
the perfusing fluid did not alter the flow rate and small amounts of one or more of
these substances (usually about 250 ,tg. 5-HT or 5-hydroxytryptophanand 2-3 mng.
5-HIAA) were added to the perfusing fluid, with the labelled tryptophan, by
means ofthe syringe (Fig. 2). At the end ofthe perfusion, furtherknownamounts
of 5-HT and 5-HIAA were added, the aromatic substances were adsorbed on
charcoal deactivated with 8 per cent by weight of octadecylamine (Asatoor and
Dalgliesh, 1956), eluted, concentrated, chromatographed, and the chromatograms
autoradiographed, and examined for radioactivity in the 5-hydroxyindoles. In
case 5-hydroxyindoles remained bound to liver tissue, a portion of the liver
immediately after perfusion was homogenized, and the homogenate extracted by
standard procedures at suitablepH for 5-HT (cf. Udenfriend, Weissbach and Clark,
1955, and this work) and 5-HIAA (cf. Udenfriend, Titus and Weissbach, 1955)
and chromatograms of the extracts were also autoradiographed. The recovery
of5-hydroxyindoles atthe concentrationsbeinghandledwas determinedinseparate
experiments. The amount of available [U-14C]tryptophan limited experiments
with labelled tryptophan to eight. In none of these experiments (in the two
most sensitive of which it was calculated that formation of 5-hydroxyindoles at
approximately 3 per cent of the known rate of production for the whole animal
20
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would have been detectable; cf. Discussion) was any radioactivity detectable in
the 5-hydroxyindoles. It was, however, noticed that both 5-HT and 5-HIAA
gave rise to derivatives, presumably conjugates, resembling in their chromato-
graphic behaviour substances noted in carcinoid urines (Dalgliesh, 1956; Smith,
Nyhus, Dalgliesh, Dutton, Lennox and Macfarlane, 1957). No direct comparison
was made, but conjugation ofphenolic substances is a normal metabolic reaction of
the liver.
Perfusion experiments with gut
For reasons outlined in the discussion we next turned our attention to perfusion
of the blood vessels of the gut. It was found that oedema occurred rapidly unless
dextran was added to the perfusate. Even in the presence of dextran the flow
rate had to be kept below 3 ml./min., and oedema developed after about 90
minutes. The dextran reduced the recovery of aromatic substances from the
deactivatedcharcoaland, more seriously, itselfappearedinthearomatic-containing
eluate and disturbed the chromatography. The aromatic substances could be
separated from the dextran by dialysis for 2 hours against a suspension of
deactivated charcoal in 5 per cent saline, but at the low levels of5-hydroxyindoles
with which we were dealing considerable losses (presumably due to oxidation)
still occurred.
When [14C]tryptophan was perfused only slight radioactivity became incor-
porated into gut protein. Metabolism was therefore obviously depressed, and we
were unable in the time available to establish conditions in which adequate
oxygenation of the tissues was occurring.
DISCUSSION
The lack of knowledge of the hydroxylation stage in 5-HT biogenesis is a
reflection of the experimental difficulties in working with hydroxylating systems
in general. In view of these difficulties considerable care has to be taken in the
acceptance of negative evidence. The negative results in our experiments with
tissue slices, homogenates and sub-cellular preparations might well be attributable
to the lability ofthe hydroxylating system. But we feel that the results ofthe liver
perfusion experiments, though negative, are significant By all the criteria applied
the livers were behaving normally and were fully oxygenated, and under these
conditions the hydroxylating system, if present, would be expected to remain
intact. Wecalculatedthatinourmostsensitiveexperimentsformationof5-hydroxy-
tryptophan at a rate greater than 3 per cent ofthe whole body rate (thewhole body
ratefor the rat is about 2-3 jtg./hour: Erspamer, 1954a) would havebeendetect-
able. The only factor in this calculation not directly measured was thepool size of
tryptophan pre-existing in the liver, which we have assumed to be 100 /ug. This
value can be derived by assuming the blood tryptophan to be 1 mg./100 ml.
(cf. e.g., Hier and Bergeim, 1946); the blood volume 15 ml., ofwhich one-third is
in the liver; and an additional amount of extra-cellular tryptophan in the liver
equal to that in the blood circulating through theliver. Onthe otherhandSheffner
and Bergeim (1954) found a free liver tryptophan level of about 21 jug./g. dry
weight, corresponding to a pool of about 50 /ug. in our animals, and a similar
result is obtained by combining the results of Dalgliesh and Tabechian (1956)
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that 1 hour after labelled tryptophan was given 90 per cent of amino acid radio-
activity was protein bound, with the results of Henriques, Henriques and Neu-
berger (1955) that 1 hour after a dose ofglycine the specific activity offree amino
acid was 40 times that ofbound amino acid. Assuming the tryptophan content of
the liver to be 25 mg. (1 per cent of dry weight) this gives a value for the free
tryptophan pool of about 50 jag. Even if our assumed figure for the tryptophan
were in error by a factor of as much as 10 the liver would still be excluded as more
than a minor site for formation of 5-hydroxytryptophan.
The pioneer work of Erspamer (review: Erspamer, 1954b) established the
close relationship between the argentaffin cells, which occur especially in the intes-
tinal mucosa, and 5-HT. The intestinal mucosa contains large amounts of 5-
hydroxytryptophan decarboxylase and there is little doubt that the 5-HT in
the argentaffin cells is formed there, and not merely accumulated and stored.
But the 5-hydroxytryptophan required as substrate for the decarboxylase might
have been formed elsewhere and carried to the argentaffin cells in the blood.
The high values for 5-hydroxytryptophan decarboxylase activity found for body
tissuesinthe present work indicate a decarboxylating capacity greatlyinexcess of
that required to account for known rates of 5-HT formation from low tissue
concentrations of 5-hydroxytryptophan. As the decarboxylation reaction cannot
therefore be rate-limiting, there is no necessity for the distribution ofthe hydroxy-
lation system to be closely linked with the decarboxylase system.
Two preliminary communications have suggested that 5-hydroxyindoles
couldbeformed from tryptophan in liver, but in neither case does anyfullaccount
of the experiments appear subsequently to have been published. Udenfriend,
Clark and Titus (1953a) claimed conversion oftryptophan to 5-hydroxytryptophan
in guinea-pig liver slices, but later (Mitoma, Weissbach and Udenfriend, 1955)
stated that the conversion was too small for definite identification. Price and
Dietrich (1956) claimedformation ofsubstances havingtheproperties of5-hydroxy-
indoles on perfusing tryptophan through rabbit livers. As our experiments
were largely on rats, with some on mice, it is possible that species differences
might be involved, though we think this unlikely to be a major factor.
During this work we encountered a patient with argentaffinoma presenting
unusual features, which have been described elsewhere (Smith et al., 1957).
Biochemically the most striking feature was the excretion ofconsiderable amounts
of 5-hydroxytryptophan, as well as of 5-HT and 5-HIAA. The most likely
explanation for this was that metastases existed in the kidney, and that the
5-hydroxytryptophan was formed in the argentaffin cells and excreted before
all was metabolized to 5-HT. The existence of kidney metastases was confirmed
clinically by intravenous pyelography, but unfortunately it was not possible to
obtain permission to do a post mortem examination.
This case seemed to us to provide strongly suggestive evidence that formation
of 5-hydroxytryptophan occurred in the argentaffin cells. We therefore turned
our attention to perfusion of the blood vessels of the gut, as the major site of
argentaffin cells is the intestinal mucosa. Unfortunately we were unable to estab-
lish conditions under which adequate oxygenation occurred. As the argentaffin
cells, even in the tissues richest in them, are comparatively few in number and in
that part of the tissue furthest from the larger tissue blood vessels, the occurrence
of an oxidative reaction in these cells is likely to be particularly sensitive to
oxygen supply.
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Thelikelihood that formation of 5-hydroxytryptophan occurs intheargentaffin
cells can also be supported on general grounds. The normal animal contains
far more 5-hydroxytryptophan decarboxylase than is required to form 5-HT
at the normal rate. The limiting factor is therefore availability of substrate.
If, as far as 5-HT is concerned, argentaffin cells were concerned only with decar-
boxylation, the presence of a large extra number of cells as in metastasizing
carcinoid would not be expected to alter 5-HT output appreciably. As 5-HT
outputis markedly raised, the increase in number ofargentaffin cells is presumably
accompanied by a correspondingincrease information ofthe 5-hydroxytryptophan
needed as substrate for the decarboxylase.
In view of the possible relation of 5-HT to brain function it is of interest that
for many years some histologists (e.g., Masson and Berger, 1923; Masson, 1928)
have considered that argentaffin cells bear a close relation to the nervous system.
We consider that our results strongly suggest that the argentaffin cells are the
main site of biosynthesis of 5-hydroxytryptophan. If this is the case the low
concentration ofargentaffin cells makes it seem likely that formation of5-hydroxy-
tryptophan will prove difficult to study by enzymic techniques except in tumour
tissue.
SUMMARY
1. The activity of 5-hydroxytryptophan decarboxylase in some tissues of
the mouse and rat is reported.
2 Experiments with rat and mouse liver slices and homogenates and rat liver
mitochondria showed no evidence for the conversion oftryptophan to 5-hydroxy-
indoles.
3. Perfusion ofrat liver, under conditions in which the evidence suggested that
liver function remained normal, gave no evidence for conversion of tryptophan
to 5-hydroxyindoles.
4. These results, taken in conjunction with evidence published elsewhere, are
considered to indicate that the major site of formation of 5-hydroxytryptophan
is the argentaffin (enterochromaffin, Kultschitzky) cell system located principally
in the intestinal mucosa.
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